These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28467330)

  • 81. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A; Papa A; Danese S
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.
    Majewski M; Reddymasu SC; Sostarich S; Foran P; McCallum RW
    Am J Med Sci; 2007 May; 333(5):266-70. PubMed ID: 17505166
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Rifaximin: new therapeutic indication and future directions.
    Rivkin A; Gim S
    Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].
    Gasztonyi B; Hunyady B
    Orv Hetil; 2004 Oct; 145(43):2177-81. PubMed ID: 15575494
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Rifaximin in the management of colonic diverticular disease.
    Latella G; Scarpignato C
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):585-98. PubMed ID: 19929580
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment of travelers' diarrhea.
    DuPont HL
    J Travel Med; 2001 Dec; 8(Suppl 2):S31-3. PubMed ID: 12186671
    [No Abstract]   [Full Text] [Related]  

  • 89. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
    Koo HL; DuPont HL
    Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Interaction between rifaximin and dietary fibre in patients with diverticular disease.
    D'Incà R; Pomerri F; Vettorato MG; Dal Pont E; Di Leo V; Ferronato A; Medici V; Sturniolo GC
    Aliment Pharmacol Ther; 2007 Apr; 25(7):771-9. PubMed ID: 17373915
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
    Pimentel M
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():37-49. PubMed ID: 26618924
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Faecal calprotectin in colonic diverticular disease: a case-control study.
    Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
    Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 94. Symptomatic Diverticulosis Is Characterized By Loose Stools.
    Järbrink-Sehgal ME; Andreasson A; Talley NJ; Agréus L; Song JY; Schmidt PT
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1763-1770.e1. PubMed ID: 27353142
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Management of colonic diverticular disease.
    Frieri G; Pimpo MT; Scarpignato C
    Digestion; 2006; 73 Suppl 1():58-66. PubMed ID: 16498253
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Patients with Diverticular Disease Have Different Dietary Habits Compared to Control Subjects: Results from an Observational Italian Study.
    Polese B; Carabotti M; Rurgo S; Ritieni C; Sarnelli G; Barbara G; Pace F; Cuomo R; Annibale B;
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432301
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey.
    Annibale B; Lahner E; Maconi G; Usai P; Marchi S; Bassotti G; Barbara G; Cuomo R
    Int J Colorectal Dis; 2012 Sep; 27(9):1151-9. PubMed ID: 22573184
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
    Adachi JA; DuPont HL
    Clin Infect Dis; 2006 Feb; 42(4):541-7. PubMed ID: 16421799
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome.
    Bruzzese E; Pesce M; Sarnelli G; Guarino A
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):753-760. PubMed ID: 29897844
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.
    Tan VP; Liu KS; Lam FY; Hung IF; Yuen MF; Leung WK
    Aliment Pharmacol Ther; 2017 Mar; 45(6):767-776. PubMed ID: 28112426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.